SEKISUI Diagnostics Metrix™ COVID-19 Test

The Metrix™ COVID-19 test includes clinical claims for symptomatic and asymptomatic individuals. It allows for an enhanced point-of-care testing experience with dual-sample types for nasal or saliva.

Supplier:  SEKISUI Diagnostics MTRXC1925PK

Catalog No. 22-321-140

Description

• Molecular accuracy without the wait - Improve clinical outcomes by administering immediate treatment in just 30 minutes.
• Accessible molecular testing - Breakthrough platform designed to eliminate cost-barriers.
• Reduce repeat testing - No need for serial or confirmation testing when nasal specimen is used.
• Alleviates testing restrictions - Indicated for symptomatic and asymptomatic testing, allowing for screening prior to medical procedures.
• Simple workflow - Can be performed in any point-of-care setting, with minimal training required.
• Convenient sampling - The only test with dual-sample types, allowing you to provide the best patient experience possible.
• Exceptional Support - Experienced support teams and online training modules to help streamline your testing implementation.

Specifications

• CE Marker: No
• Detectable Analytes: COVID-19
• Type: COVID-19 Test
• For Use With (Application): Point-of-Care Testing
• Sterility: Sterile
• Form: Liquid Ready-to-Use

• Clia Complexity: Waived (FDA, EUA)
• DoA Calibrators: No
• Disposable: Reusable
• Includes: 25 Tests
• Test Time: 30 min.